This is supported by a recent report in a model of myocardial infarction in which EPO increased VEGF protein expression and improved revascularisation of the ischaemic myocardium; administration of VEGF-neutralizing antibodies prevented this EPO-mediated enhancement of cardiac revascularisation [38]. This evidence concerns the gene VEGFA and myocardial infarction.